Monday, February 19, 2018
FDA Grants Marketing Authorization to Banyan Biomarkers for the First Diagnostic Blood Test for Traumatic Brain Injury

Banyan BTI is the first in vitro diagnostic blood test to aid in the evaluation of patients with suspected TBI, also known as concussion.  ..

Read More
Wednesday, February 01, 2017
bioMérieux and Banyan Biomarkers Partner to Develop, Validate and Market Blood-Based Biomarkers for Traumatic Brain Injury

Under the terms of the agreement, bioMérieux takes an equity participation of about $7 million in Banyan Biomarkers and obtains the rights to commercialize Banyan’s proprietary tests worldwide for use in in vitro diagnostics, with preferred rights for its VIDAS® immunoassays range. ..

Read More
Monday, August 01, 2016
Quanterix and Banyan Biomarkers Join Together to Address Traumatic Brain Injury Head On

With this agreement, the two companies will provide the tools and solutions necessary to support critical advancements in neurology research. ..

Read More
Friday, January 08, 2016
Philips and Banyan Biomarkers Partner to Develop and Commercialize New Handheld Blood Test to Detect and Evaluate Concussions

The collaboration unites Philips’ strength in patient monitoring and handheld diagnostics technologies, as well as, clinical decision support applications for use in acute care settings, and Banyan Biomarkers’ knowledge of biomolecules that are indicative of neurological injuries.  ..

Read More
Friday, July 24, 2015
Banyan Biomarkers, Inc. Selected as Final Winner of GE and NFL Head Health Challenge I

The $500,000 award will be used to conduct research on over twenty brain injury biomarkers to help understand the effects of concussion in contact sports.  ..

Read More
Thursday, August 28, 2014
Banyan Biomarkers, Inc. Licenses Protein Markers to Help Evaluate Traumatic Brain Injury

Banyan Biomarkers, Inc. announced that the company has licensed its intellectual property related to traumatic brain injury (TBI) biomarkers to Abbott for assessment and verification. The terms of the agreement were not disclosed. ..

Read More
Friday, January 24, 2014
UF and Banyan Biomarkers Inc. to conduct NFL/GE-funded concussion research

Banyan Biomarkers Inc. announced today that it has received a $300,000 award from the NFL and General Electric to improve detection of concussions through research led by a University of Florida football team physician. ..

Read More
Thursday, August 04, 2011
Banyan Biomarkers, Inc. Works with Emory University to Analyze Biomarkers in the Clinical Trial of Progesterone in Traumatic Brain Injury

Banyan Biomarkers, Inc. will partner with Emory University through a grant from the National Institutes of Health to measure biomarkers in the blood of traumatic brain injury (TBI) patients. The five-year grant of $2.2 million was awarded to Michael Frankel, MD, Professor of Neurology at Emory School of Medicine, with partners Banyan Biomarkers, Inc., the Medical University of South Carolina, the University of Pittsburgh and the University of Michigan. The research team will study biomarkers in the blood of TBI patients enrolled in the phase III clinical trial, ProTECT III (Progesterone for Traumatic Brain Injury, Experimental Clinical Treatment), which is assessing the efficacy of progesterone in the treatment of TBI.
Read more... ..

Read More